Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

Mackenzie MacDonald; I.S. MacKenzie; L. Wei; C.J. Hawkey; D.E. Grobbee; x Scot Study group collaborators; I. Ford

doi:10.1136/bmjopen-2012-002295

Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

Translated title of the contribution: Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

Mackenzie MacDonald, I.S. MacKenzie, L. Wei, C.J. Hawkey, D.E. Grobbee, x Scot Study group collaborators, I. Ford

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).
Original language	Undefined/Unknown
Pages (from-to)	e002295
Number of pages	1
Journal	BMJ open [E]
Volume	29
Issue number	3
DOIs	https://doi.org/10.1136/bmjopen-2012-002295
Publication status	Published - 2013

Access to Document

10.1136/bmjopen-2012-002295

http://www.ncbi.nlm.nih.gov/pubmed/23364320

Cite this

MacDonald, M., MacKenzie, I. S., Wei, L., Hawkey, C. J., Grobbee, D. E., Scot Study group collaborators, X., & Ford, I. (2013). Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). BMJ open [E], 29(3), e002295. https://doi.org/10.1136/bmjopen-2012-002295

MacDonald, Mackenzie ; MacKenzie, I.S. ; Wei, L. et al. / Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). In: BMJ open [E]. 2013 ; Vol. 29, No. 3. pp. e002295.

@article{d5e7092f17c34d55bb6f5f29a0db964b,

title = "Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).",

author = "Mackenzie MacDonald and I.S. MacKenzie and L. Wei and C.J. Hawkey and D.E. Grobbee and \{Scot Study group collaborators\}, x and I. Ford",

year = "2013",

doi = "10.1136/bmjopen-2012-002295",

language = "Undefined/Unknown",

volume = "29",

pages = "e002295",

journal = "BMJ open [E]",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "3",

}

MacDonald, M, MacKenzie, IS, Wei, L, Hawkey, CJ, Grobbee, DE, Scot Study group collaborators, X & Ford, I 2013, 'Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).', BMJ open [E], vol. 29, no. 3, pp. e002295. https://doi.org/10.1136/bmjopen-2012-002295

Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). / MacDonald, Mackenzie; MacKenzie, I.S.; Wei, L. et al.
In: BMJ open [E], Vol. 29, No. 3, 2013, p. e002295.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

AU - MacDonald, Mackenzie

AU - MacKenzie, I.S.

AU - Wei, L.

AU - Hawkey, C.J.

AU - Grobbee, D.E.

AU - Scot Study group collaborators, x

AU - Ford, I.

PY - 2013

Y1 - 2013

U2 - 10.1136/bmjopen-2012-002295

DO - 10.1136/bmjopen-2012-002295

M3 - Article

C2 - 23364320

SN - 2044-6055

VL - 29

SP - e002295

JO - BMJ open [E]

JF - BMJ open [E]

IS - 3

ER -

MacDonald M, MacKenzie IS, Wei L, Hawkey CJ, Grobbee DE, Scot Study group collaborators X et al. Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). BMJ open [E]. 2013;29(3):e002295. doi: 10.1136/bmjopen-2012-002295